13F HOLDINGS REPORT
Northpond Ventures, LLC
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001104659-24-089657
Total Value
$55.3M
Positions
4
Other Managers
0
Confidential Omitted
No
Holdings (4)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | KYVERNA THERAPEUTICS INC | KYTX | 3,255,426 | $24.4M | 44.18% |
| 2 | VIGIL NEUROSCIENCE INC | 92673K108 | 4,214,498 | $16.9M | 30.50% |
| 3 | CANDEL THERAPEUTICS INC | CADL | 1,935,215 | $12.0M | 21.71% |
| 4 | TELESIS BIO INC | 192003200 | 546,897 | $2.0M | 3.61% |